Navigation Links
InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
Date:12/3/2008

Cellastim, an animal-free recombinant albumin product manufactured by InVitria, can outperform animal and human derived serum in CHO cell culture.

Fort Collins, CO (PRWEB) December 3, 2008 -- Cellastim has proven to be a robust replacement for serum derived albumin in CHO media and can improve both the growth kinetics and productivity of CHO cell lines across a variety of chemically defined media.

Studies support InVitria's claim that its Cellastim Cellastim outperforms other chemically defined cell culture ingredients and can be used by the biopharmaceutical, mammalian cell culture, stem cell and regenerative medicine industries as a supplement for cell culture media.

Cellastim is a defined supplement that can enhance performance of chemically defined media. One study revealed that Cellastim outperformed plasma-derived human serum albumin with a 50% average increase in productivity in several chemically defined cell culture media.

"InVitria's Cellastim helps optimize cell culture media performance safely and effectively," said InVitria President Scott Deeter. "As a regulatory friendly product, Cellastim can provide researchers an option to free their cells from the risk of potentially harmful contaminants, while simultaneously enhancing cell growth and productivity."

The conversion from serum supplemented media to serum-free media for production of biopharmaceuticals in CHO cells is essential for the elimination of all animal components in the culturing media. The addition of InVitria's Cellastim offers optimal defined quality and safety for the production of biopharmaceuticals in CHO cells.

About InVitria:
InVitria has developed defined and animal-free cell culture media components that enhance cell growth, productivity, safety and time to market for companies in the biopharmaceutical, mammalian cell culture, regenerative medicine, cell therapy, stem cell and diagnostics industry. Cellastim is an animal free component used to enhance cell growth and productivity in cell culture media.

For more information about InVitria's products or to place an order, please contact InVitria's sales and marketing team by e-mail or phone.

E-mail: info (at) InVitria.com         
Phone: 1-800-916-8311

###

Read the full story at http://www.prweb.com/releases/CHOCellCulture/Cellastim/prweb1702944.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Internet Service Delivers Relief to Families of Those in Long-Term Care
2. New Software Streamlines Interface Management, Delivers More System Security and Greater IT Control
3. Healthplace America Delivers the First and Only Surgery Benefit Management Solution Through the Healthplace Benefit(TM)
4. Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008.
5. Decision Intelligence Delivers Marketing Contact Optimization Solutions
6. Illinois Commerce Commission Delivers $207 Million Ameren Rate Hike
7. Pennsylvania Commission for Women Delivers First Womens Wellness Guide Kiosk to Allegheny County Jail
8. SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients
9. Specialty Renal Pharmacy Delivers One Millionth Prescription
10. Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008
11. New Website Portal Delivers Pre-Qualified Spinal Decompression Patients to Participating Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma Solutions, the ... and consumer health products, today announced that it had joined the Pharmaceutical Supply ... non-profit organization to unite pharmaceutical and healthcare companies that share a vision of ...
(Date:12/8/2016)... Ga (PRWEB) , ... December 08, 2016 , ... ... as soon after surgery as possible. With this in mind, SIGVARIS has created ... (DVT or blood clot) during bed rest and provide the benefits of graduated ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... financial planning services from offices headquartered in Hamilton County, is embarking on a ... , LuvFurMutts specializes in finding new homes for orphaned or neglected senior dogs ...
(Date:12/8/2016)... , ... December 08, 2016 , ... The Compretta Insurance ... and residential clients in and around the Hancock County area, is announcing the launch ... County Food Pantry. , The Hancock County Food Pantry has worked for more than ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... will have the unique opportunity to get hands-on experience in an emergency medical ... an immersive experience to gain invaluable, real-life medical skills that are critical success ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016  A new study by a pair ... of opioid therapy to treat chronic pain is not ... more harmful consequences, including death. Palliative care ... Zankhana Mehta , M.D., authored the study which provides ... therapy. The study was published in the December 2016 ...
(Date:12/8/2016)... 2016 Mederi Therapeutics Inc . hat die behördliche Zulassung ... für gastroösophageale Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast ... of Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)... , December 8, 2016 According ... Diabetes Injection Pens Market is expected to be worth ... US$4.9 bn in 2015. Between the forecast years of 2016 ... a CAGR of 7.9%. The leading players operating in the ... Lilly and Company, AstraZaneca plc., Biocon Ltd., and Sanofi S.A. ...
Breaking Medicine Technology: